TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97 | -27.1% | 206 | 0.0% | 0.00% | – |
| Q2 2023 | $133 | -21.8% | 206 | 0.0% | 0.00% | – |
| Q1 2023 | $170 | +5.6% | 206 | 0.0% | 0.00% | – |
| Q4 2022 | $161 | – | 206 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 206 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 206 | -8.0% | 0.00% | – |
| Q4 2021 | $0 | – | 224 | +8.7% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 206 | -25.4% | 0.00% | – |
| Q2 2021 | $1,000 | – | 276 | +100.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 138 | -97.7% | 0.00% | – |
| Q4 2020 | $20,000 | – | 6,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 39,820 | $119,000 | 0.02% |
| Westside Investment Management, Inc. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $69 | 0.00% |
| JPMORGAN CHASE & CO | 78 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 17 | $0 | 0.00% |
| VANGUARD GROUP INC | 72,791 | $217,000 | 0.00% |
| UBS Group AG | 23,459 | $70,000 | 0.00% |
| Sowell Financial Services LLC | 19 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 15 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 138 | $0 | 0.00% |